Brief Reports
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Feb 14, 2005; 11(6): 871-874
Published online Feb 14, 2005. doi: 10.3748/wjg.v11.i6.871
Table 1 Relationship of the MMP-9 expression and clinicopathological parameters.
Clinicopathological parametersMMP-9 expression
χ2P
Positive cases (%)Negative cases (%)
Age (yr)<6044 (49.4)45 (50.6)0.010.921
>6058 (48.7)61 (51.3)
SexMale74 (45.7)88 (54.3)3.3080.069
Female28 (60.9)18 (39.1)
Tumor locationUpper8 (50.0)8 (50.0)1.4840.476
Middle69 (51.9)64 (48.1)
Lower25 (42.4)34 (57.6)
Tumor cell differentiationWell25 (32.5)52 (67.5)13.5030.001
Middle46 (59.7)31 (40.3)
Poor31 (57.4)23 (42.6)
Vessel permeationAbsent75 (45.2)91 (54.8)4.8960.027
Present27 (64.3)15 (35.7)
Tumor invasion (T)T18 (57.1)6 (42.9)1.3050.521
T219 (42.2)26 (57.8)
T375 (50.3)74 (49.7)
Lymph node metastasis (N)N045 (41.7)63 (58.3)4.8850.027
N157 (57.0)43 (43.0)
TNM stageI7 (58.3)5 (41.7)7.1390.068
IIa38 (39.6)58 (60.4)
IIb7 (46.7)8 (53.3)
III50 (58.8)35 (41.2)